-
Ipsen pharma
- Vice President global strategic marketing & Portfolio strategy
2015 - maintenant
Global marketing strategy of OTX/OTC portfolio
Head of LCM strategy and bew product development
Primary Care business Unit
-
Biofortis, a Mérieux NutriSciences company
- Managing Director Europe
2011 - maintenant
-
Merck CH
- Global Innovation Director
2009 - maintenant
France et Allemagne
Responsibilities
• Overall responsibility for driving forward and delivering development projects
• Foster innovation and partnerships, support regional roll-out of existing food supplement products
• Technical, regulatory, medical science, clinical, portfolio management, supply, in-licensing
-
Reckitt Benckiser
- Global Marketing Manager
Massy
2006 - 2006
UK
Analgesics / Reckitt Benckiser Corporate
Responsibilities
• Re-alignment of the medium and long term business with Reckitt’s strategy
• Team leader for the development of new products, International TV copy, best practices
-
Merck CH
- Global Strategic Marketing Director
2006 - 2009
Allemagne
Responsibilities
• Everyday Health Protection (leading segment at 149 M€) + Cough & Cold (104 M€): Bion/Multibionta, (Probiotics), Cebion, Diabion (Vitamins) and Nasivin
• Delivery of a global strategy to make power brands: re-positioning, new communication strategies and tools, brand stretch, NPD ideation, packaging, guidelines, and best practices.
• Support and control of the local implementations, support for geographic expansion and acquisition
-
Boots Healthcare International (BHI)
- Europe Marketing Manager
2004 - 2006
Analgesic business / BHI
Nurofen® , 1st International BHI business
Responsibilities
• 15 countries / 110 M€ of sales (Nurofen® , Nureflex®, Junifen®, Adulfen®, Reflex®,...)
• P&L responsibility, brand portfolio, European strategy and local marketing plans
• 7 direct reports
-
Boots Healthcare International (BHI)
- Marketing Manager
2002 - 2004
Analgesic and Cold & Flue (Nurofen® OTC – Nureflex® Prescription)
Responsibilities: Marketing and external HCP detailing
• Sales : 30 M€, including Nurofen, the 1st OTC brand in France
• 6 marketing direct reports, 1detailing manager
-
Aventis Pharma (Consumer - Theraplix)
- Chef de Gamme
2001 - 2002
Analgesic Range Manager Topalgic® / Propofan®
Responsibilities
• Turnover : 106 M€
. 2 line reports
-
Aventis (consumer - Theraplix)
- Chef de produit Senior
2000 - 2001
Senior Product Manager: Doliprane®
Responsibilities
• Turnover = 113 M€ - Leading brand on French analgesic market and 1st Aventis French turnover
• 2 line reports
-
Aventis (consumer - Therapix)
- Chef de produit
1998 - 2000
Product Manager – Toplexil®, Bronchokod®
Responsibilities
• Sales = 39M€, leaders of market.
-
Aventis Pharma
- Delegue Medical
Antony
1996 - 1998
Reseau ville - secteur 93
Medecine de ville: generalistes, rhumatologues, gynecologues
Hopitaux: urgences et services de Rhumatologie
-
Aventis Pharma
- Assistant Etudes de Marche
Antony
1994 - 1995
Assistant Etudes - Panels quantitatifs
